Disclosure and Transfer to Salix of Intellectual Property. Forthwith following the Effective Date and from time to time during the Initial Term Debiovision: 2.7.1 shall disclose and make available to Salix all Intellectual Property; 2.7.2 acknowledges that all Intellectual Property created, acquired or developed after the Effective Date and during the Initial Term is licensed to Salix under the terms of Clause 2.1; and 2.7.3 shall on request, to the extent legally possible give Salix full access to any regulatory dossier related to a Product filed outside the Territory in connection with Commercialisation of such Product by Salix in the Territory.
Appears in 2 contracts
Sources: Development and License Agreement, Development and License Agreement (Salix Pharmaceuticals LTD)